Takaisin Tulosta

Kohonnut verenpaine, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
10.9.2020

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Kohonnut verenpaine «Kohonnut verenpaine»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Aburto NJ, Hanson S, Gutierrez H ym. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013;346:f1378 «PMID: 23558164»PubMed
  2. ACCORD Study Group., Cushman WC, Evans GW ym. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-85 «PMID: 20228401»PubMed
  3. Allender PS, Cutler JA, Follmann D ym. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 1996;124:825-31 «PMID: 8610952»PubMed
  4. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97 «PMID: 12479763»PubMed
  5. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA ym. Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 2006;47:1576-83 «PMID: 16630993»PubMed
  6. Appel LJ, Moore TJ, Obarzanek E ym. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997;336:1117-24 «PMID: 9099655»PubMed
  7. Appel LJ, Wright JT Jr, Greene T ym. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010;363:918-29 «PMID: 20818902»PubMed
  8. Bangalore S, Kumar S, Lobach I ym. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation 2011;123:2799-810, 9 p following 810 «PMID: 21632497»PubMed
  9. Beard TC, Cooke HM, Gray WR ym. Randomised controlled trial of a no-added-sodium diet for mild hypertension. Lancet 1982;2:455-8 «PMID: 6125636»PubMed
  10. Beckett N, Peters R, Tuomilehto J ym. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2011;344:d7541 «PMID: 22218098»PubMed
  11. Beckett NS, Peters R, Fletcher AE ym. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98 «PMID: 18378519»PubMed
  12. Benetos A, Petrovic M, Strandberg T. Hypertension Management in Older and Frail Older Patients. Circ Res 2019;124:1045-1060 «PMID: 30920928»PubMed
  13. Brenner BM, Cooper ME, de Zeeuw D ym. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9 «PMID: 11565518»PubMed
  14. Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ 2016;352:i717 «PMID: 26920333»PubMed
  15. Bucher HC, Cook RJ, Guyatt GH ym. Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA 1996;275:1016-22 «PMID: 8596234»PubMed
  16. Campbell F, Dickinson HO, Critchley JA ym. A systematic review of fish-oil supplements for the prevention and treatment of hypertension. Eur J Prev Cardiol 2013;20:107-20 «PMID: 22345681»PubMed
  17. Can non-pharmacological interventions reduce doses of drugs needed for the treatment of hypertension? World Hypertension League. Bull World Health Organ 1992;70:685-90 «PMID: 1486664»PubMed
  18. Carlson DJ, Dieberg G, Hess NC ym. Isometric exercise training for blood pressure management: a systematic review and meta-analysis. Mayo Clin Proc 2014;89:327-34 «PMID: 24582191»PubMed
  19. Carney SL, Gillies AH, Smith AJ ym. Effect of dietary sodium restriction on patients receiving antihypertensive medication. Clin Exp Hypertens A 1984;6:1095-105 «PMID: 6744639»PubMed
  20. Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994;50:272-98 «PMID: 8205459»PubMed
  21. Collins R, Peto R, MacMahon S ym. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38 «PMID: 1969567»PubMed
  22. Cornelissen VA, Buys R, Smart NA. Endurance exercise beneficially affects ambulatory blood pressure: a systematic review and meta-analysis. J Hypertens 2013;31:639-48 «PMID: 23325392»PubMed
  23. Cornelissen VA, Fagard RH, Coeckelberghs E ym. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension 2011;58:950-8 «PMID: 21896934»PubMed
  24. Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc 2013;2:e004473 «PMID: 23525435»PubMed
  25. Curb JD, Pressel SL, Cutler JA ym. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-92 «PMID: 8968014»PubMed
  26. Cushman WC, Cutler JA, Hanna E ym. Prevention and Treatment of Hypertension Study (PATHS): effects of an alcohol treatment program on blood pressure. Arch Intern Med 1998;158:1197-207 «PMID: 9625399»PubMed
  27. Cuspidi C, Esposito A, Negri F ym. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? Am J Hypertens 2008;21:458-63 «PMID: 18369363»PubMed
  28. Dahlöf B, Devereux RB, Kjeldsen SE ym. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003 «PMID: 11937178»PubMed
  29. Dahlöf B, Gosse P, Guéret P ym. Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005;23:2063-70 «PMID: 16208150»PubMed
  30. Devereux RB, Dahlöf B, Gerdts E ym. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004;110:1456-62 «PMID: 15326072»PubMed
  31. Diao D, Wright JM, Cundiff DK ym. Pharmacotherapy for mild hypertension. Cochrane Database Syst Rev 2012;:CD006742 «PMID: 22895954»PubMed
  32. Dickinson HO, Nicolson DJ, Campbell F ym. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev 2006;:CD004640 «PMID: 16856052»PubMed
  33. Dickinson HO, Nicolson DJ, Campbell F ym. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006;:CD004641 «PMID: 16856053»PubMed
  34. Dickinson HO, Nicolson DJ, Cook JV ym. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006;:CD004639 «PMID: 16625609»PubMed
  35. Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group.. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002;360:752-60 «PMID: 12241832»PubMed
  36. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000;355:253-9 «PMID: 10675071»PubMed
  37. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52 «PMID: 4914579»PubMed
  38. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ 1998;317:713-20 «PMID: 9732338»PubMed
  39. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007;369:201-7 «PMID: 17240286»PubMed
  40. Erwteman TM, Nagelkerke N, Lubsen J ym. Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. Br Med J (Clin Res Ed) 1984;289:406-9 «PMID: 6432119»PubMed
  41. Estacio RO, Jeffers BW, Gifford N ym. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23 Suppl 2:B54-64 «PMID: 10860192»PubMed
  42. Estacio RO, Jeffers BW, Hiatt WR ym. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338:645-52 «PMID: 9486993»PubMed
  43. Ettehad D, Emdin CA, Kiran A ym. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957-967 «PMID: 26724178»PubMed
  44. Fagard RH, Celis H, Thijs L ym. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension 2009;54:1084-91 «PMID: 19770405»PubMed
  45. Filippini T, Violi F, D'Amico R ym. The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis. Int J Cardiol 2017;230:127-135 «PMID: 28024910»PubMed
  46. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1979;242:2562-71 «PMID: 490882»PubMed
  47. Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group. JAMA 1982;247:633-8 «PMID: 7033578»PubMed
  48. Forette F, Seux ML, Staessen JA ym. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002;162:2046-52 «PMID: 12374512»PubMed
  49. Furie KL, Kasner SE, Adams RJ ym. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:227-76 «PMID: 20966421»PubMed
  50. Geleijnse JM, Giltay EJ, Grobbee DE ym. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-9 «PMID: 12172309»PubMed
  51. Gottdiener JS, Reda DJ, Massie BM ym. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation 1997;95:2007-14 «PMID: 9133508»PubMed
  52. Graudal NA, Hubeck-Graudal T, Jürgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012;25:1-15 «PMID: 22068710»PubMed
  53. Grimm RH Jr, Flack JM, Grandits GA ym. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996;275:1549-56 «PMID: 8622245»PubMed
  54. Grimm RH Jr, Grandits GA, Cutler JA ym. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997;157:638-48 «PMID: 9080918»PubMed
  55. Grimm RH Jr, Grandits GA, Prineas RJ ym. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension 1997;29:8-14 «PMID: 9039073»PubMed
  56. Gueyffier F, Bulpitt C, Boissel JP ym. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 1999;353:793-6 «PMID: 10459960»PubMed
  57. Gupta AK, Dahlof B, Dobson J ym. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care 2008;31:982-8 «PMID: 18235048»PubMed
  58. Hansson L, Hedner T, Lund-Johansen P ym. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000;356:359-65 «PMID: 10972367»PubMed
  59. Hansson L, Lindholm LH, Ekbom T ym. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999;354:1751-6 «PMID: 10577635»PubMed
  60. Hansson L, Lindholm LH, Niskanen L ym. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353:611-6 «PMID: 10030325»PubMed
  61. Hansson L, Zanchetti A, Carruthers SG ym. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62 «PMID: 9635947»PubMed
  62. He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2013;:CD004937 «PMID: 23633321»PubMed
  63. Hinderliter A, Sherwood A, Gullette EC ym. Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Arch Intern Med 2002;162:1333-9 «PMID: 12076231»PubMed
  64. Holman RR, Paul SK, Bethel MA ym. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008;359:1565-76 «PMID: 18784091»PubMed
  65. Houlihan CA, Allen TJ, Baxter AL ym. A low-sodium diet potentiates the effects of losartan in type 2 diabetes. Diabetes Care 2002;25:663-71 «PMID: 11919122»PubMed
  66. Hypertension Detection and Follow-up Program Cooperative Group.. The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program. N Engl J Med 1982;307:976-80 «PMID: 7110301»PubMed
  67. Iadecola C, Gottesman RF. Neurovascular and Cognitive Dysfunction in Hypertension. Circ Res 2019;124:1025-1044 «PMID: 30920929»PubMed
  68. JATOS Study Group.. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008;31:2115-27 «PMID: 19139601»PubMed
  69. John JH, Ziebland S, Yudkin P ym. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359:1969-74 «PMID: 12076551»PubMed
  70. Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 1994;89:1023-31 «PMID: 8124787»PubMed
  71. Kasiske BL, Ma JZ, Kalil RS ym. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995;122:133-41 «PMID: 7992988»PubMed
  72. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012;66:411-8 «PMID: 22318649»PubMed
  73. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006;174:1737-42 «PMID: 16754904»PubMed
  74. Kjeldsen SE, Dahlöf B, Devereux RB ym. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 2002;288:1491-8 «PMID: 12243636»PubMed
  75. Klahr S, Levey AS, Beck GJ ym. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-84 «PMID: 8114857»PubMed
  76. Klingbeil AU, Schneider M, Martus P ym. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003;115:41-6 «PMID: 12867233»PubMed
  77. Kostis JB, Wilson AC, Freudenberger RS ym. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35 «PMID: 15619390»PubMed
  78. Lakshman MR, Reda DJ, Materson BJ ym. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 1999;159:551-8 «PMID: 10090111»PubMed
  79. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ 1991;302:819-24 «PMID: 1827353»PubMed
  80. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. BMJ 1991;302:811-5 «PMID: 2025703»PubMed
  81. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665 «PMID: 19454737»PubMed
  82. Law MR, Wald NJ, Morris JK ym. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427 «PMID: 12829555»PubMed
  83. Lawes CM, Bennett DA, Feigin VL ym. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35:776-85 «PMID: 14976329»PubMed
  84. Lewis EJ, Hunsicker LG, Clarke WR ym. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60 «PMID: 11565517»PubMed
  85. Li Z, Li Y, Liu Y ym. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs: A network meta-analysis. J Clin Hypertens (Greenwich) 2017;19:1348-1356 «PMID: 29067768»PubMed
  86. Liebson PR, Grandits GA, Dianzumba S ym. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1995;91:698-706 «PMID: 7828296»PubMed
  87. Lièvre M, Gueyffier F, Ekbom T ym. Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee. Diabetes Care 2000;23 Suppl 2:B65-71 «PMID: 10860193»PubMed
  88. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005;366:1545-53 «PMID: 16257341»PubMed
  89. Lindholm LH, Ibsen H, Dahlöf B ym. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:1004-10 «PMID: 11937179»PubMed
  90. Lipsitz LA. A 91-year-old woman with difficult-to-control hypertension: a clinical review. JAMA 2013;310:1274-80 «PMID: 24065014»PubMed
  91. Lithell H, Hansson L, Skoog I ym. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003;21:875-86 «PMID: 12714861»PubMed
  92. Liu L, Zhang Y, Liu G ym. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005;23:2157-72 «PMID: 16269957»PubMed
  93. Lonn EM, Bosch J, López-Jaramillo P ym. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med 2016;374:2009-20 «PMID: 27041480»PubMed
  94. Lv J, Ehteshami P, Sarnak MJ ym. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ 2013;185:949-57 «PMID: 23798459»PubMed
  95. MacGregor GA, Markandu ND, Singer DR ym. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) 1987;294:531-4 «PMID: 3103761»PubMed
  96. MacMahon SW, Wilcken DE, Macdonald GJ. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986;314:334-9 «PMID: 2935737»PubMed
  97. Malhotra R, Nguyen HA, Benavente O ym. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis. JAMA Intern Med 2017;177:1498-1505 «PMID: 28873137»PubMed
  98. Materson BJ, Reda DJ, Cushman WC ym. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-21 «PMID: 8446138»PubMed
  99. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992;304:405-12 «PMID: 1445513»PubMed
  100. Midgley JP, Matthew AG, Greenwood CM ym. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996;275:1590-7 «PMID: 8622251»PubMed
  101. Millar PJ, McGowan CL, Cornelissen VA ym. Evidence for the role of isometric exercise training in reducing blood pressure: potential mechanisms and future directions. Sports Med 2014;44:345-56 «PMID: 24174307»PubMed
  102. Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014;27:885-96 «PMID: 24610882»PubMed
  103. Moll van Charante EP, Richard E, Eurelings LS ym. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet 2016;388:797-805 «PMID: 27474376»PubMed
  104. Mori TA, Bao DQ, Burke V ym. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999;34:253-60 «PMID: 10454450»PubMed
  105. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33 «PMID: 8339414»PubMed
  106. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) 1985;291:97-104 «PMID: 2861880»PubMed
  107. Navis G, de Jong PE, Donker AJ ym. Moderate sodium restriction in hypertensive subjects: renal effects of ACE-inhibition. Kidney Int 1987;31:815-9 «PMID: 3033389»PubMed
  108. Neaton JD, Grimm RH Jr, Prineas RJ ym. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993;270:713-24 «PMID: 8336373»PubMed
  109. Ogihara T, Saruta T, Rakugi H ym. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010;56:196-202 «PMID: 20530299»PubMed
  110. Owens CJ, Brackett NC Jr. Role of sodium intake in the antihypertensive effect of propranolol. South Med J 1978;71:43-6 «PMID: 622601»PubMed
  111. Pahor M, Psaty BM, Alderman MH ym. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000;356:1949-54 «PMID: 11130522»PubMed
  112. Parijs J, Joossens JV, Van der Linden L ym. Moderate sodium restriction and diuretics in the treatment of hypertension. Am Heart J 1973;85:22-34 «PMID: 4564947»PubMed
  113. Patel A, ADVANCE Collaborative Group., MacMahon S ym. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40 «PMID: 17765963»PubMed
  114. Peters R, Beckett N, Forette F ym. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-9 «PMID: 18614402»PubMed
  115. Pfeffer MA, McMurray JJ, Velazquez EJ ym. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003;349:1893-906 «PMID: 14610160»PubMed
  116. Philipp T, Anlauf M, Distler A ym. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. BMJ 1997;315:154-9 «PMID: 9251545»PubMed
  117. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255-64 «PMID: 2046107»PubMed
  118. PROGRESS Collaborative Group.. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41 «PMID: 11589932»PubMed
  119. Psaty BM, Lumley T, Furberg CD ym. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003;289:2534-44 «PMID: 12759325»PubMed
  120. Psaty BM, Smith NL, Siscovick DS ym. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277:739-45 «PMID: 9042847»PubMed
  121. Puddey IB, Beilin LJ, Vandongen R ym. Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial. Hypertension 1985;7:707-13 «PMID: 3897044»PubMed
  122. Puddey IB, Beilin LJ, Vandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial. Lancet 1987;1:647-51 «PMID: 2882082»PubMed
  123. Rahman F, McEvoy JW, Ohkuma T ym. Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus. Hypertension 2019;73:1291-1299 «PMID: 31030606»PubMed
  124. Ram CV, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 1981;141:1015-9 «PMID: 7247587»PubMed
  125. Roerecke M, Kaczorowski J, Tobe SW ym. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health 2017;2:e108-e120 «PMID: 29253389»PubMed
  126. Rossi AM, Moullec G, Lavoie KL ym. The evolution of a Canadian Hypertension Education Program recommendation: the impact of resistance training on resting blood pressure in adults as an example. Can J Cardiol 2013;29:622-7 «PMID: 23541664»PubMed
  127. Rouch L, Cestac P, Hanon O ym. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 2015;29:113-30 «PMID: 25700645»PubMed
  128. Ruggenenti P, Perna A, Loriga G ym. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 2005;365:939-46 «PMID: 15766995»PubMed
  129. Sacks FM, Svetkey LP, Vollmer WM ym. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10 «PMID: 11136953»PubMed
  130. Saiz LC, Gorricho J, Garjón J ym. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Cochrane Database Syst Rev 2018;7:CD010315 «PMID: 30027631»PubMed
  131. Sarnak MJ, Greene T, Wang X ym. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med 2005;142:342-51 «PMID: 15738453»PubMed
  132. Schall P, Wehling M. Treatment of arterial hypertension in the very elderly: a meta-analysis of clinical trials. Arzneimittelforschung 2011;61:221-8 «PMID: 21650080»PubMed
  133. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-13 «PMID: 8622227»PubMed
  134. Schmieder RE, Schlaich MP, Klingbeil AU ym. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant 1998;13:564-9 «PMID: 9550628»PubMed
  135. Schrader J, Lüders S, Kulschewski A ym. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 2005;36:1218-26 «PMID: 15879332»PubMed
  136. Siebenhofer A, Jeitler K, Horvath K ym. Long-term effects of weight-reducing drugs in people with hypertension. Cochrane Database Syst Rev 2016;3:CD007654 «PMID: 26934640»PubMed
  137. Singer DR, Markandu ND, Cappuccio FP ym. Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension 1995;25:1042-4 «PMID: 7737713»PubMed
  138. SPRINT MIND Investigators for the SPRINT Research Group., Williamson JD, Pajewski NM ym. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA 2019;321:553-561 «PMID: 30688979»PubMed
  139. SPRINT Research Group., Wright JT Jr, Williamson JD ym. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015;373:2103-16 «PMID: 26551272»PubMed
  140. Staessen JA, Fagard R, Thijs L ym. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64 «PMID: 9297994»PubMed
  141. Staessen JA, Gasowski J, Wang JG ym. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355:865-72 «PMID: 10752701»PubMed
  142. Streppel MT, Arends LR, van 't Veer P ym. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005;165:150-6 «PMID: 15668359»PubMed
  143. Tatti P, Pahor M, Byington RP ym. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998;21:597-603 «PMID: 9571349»PubMed
  144. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators., Yusuf S, Teo K ym. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008;372:1174-83 «PMID: 18757085»PubMed
  145. The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1980;1:1261-7 «PMID: 6104081»PubMed
  146. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13 «PMID: 9732337»PubMed
  147. Tuomilehto J, Rastenyte D, Birkenhäger WH ym. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999;340:677-84 «PMID: 10053176»PubMed
  148. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration.. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003;362:1527-35 «PMID: 14615107»PubMed
  149. Tzourio C, Anderson C, Chapman N ym. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75 «PMID: 12742805»PubMed
  150. Ueshima H, Mikawa K, Baba S ym. Effect of reduced alcohol consumption on blood pressure in untreated hypertensive men. Hypertension 1993;21:248-52 «PMID: 8428787»PubMed
  151. Wald DS, Law M, Morris JK ym. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009;122:290-300 «PMID: 19272490»PubMed
  152. van Brummelen P, Schalekamp M, de Graeff J. Influence of sodium intake on hydrochlorothiazide-induced changes in blood pressure, serum electrolytes, renin and aldosterone in essential hypertension. Acta Med Scand 1978;204:151-7 «PMID: 696414»PubMed
  153. van Mierlo LA, Arends LR, Streppel MT ym. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006;20:571-80 «PMID: 16673011»PubMed
  154. Warwick J, Falaschetti E, Rockwood K ym. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med 2015;13:78 «PMID: 25880068»PubMed
  155. Weinberger MH, Cohen SJ, Miller JZ ym. Dietary sodium restriction as adjunctive treatment of hypertension. JAMA 1988;259:2561-5 «PMID: 3357230»PubMed
  156. Verdecchia P, Angeli F, Borgioni C ym. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 2003;16:895-9 «PMID: 14573325»PubMed
  157. Verdecchia P, Staessen JA, Angeli F ym. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 2009;374:525-33 «PMID: 19683638»PubMed
  158. Whelton PK, He J, Cutler JA ym. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32 «PMID: 9168293»PubMed
  159. Whelton SP, Hyre AD, Pedersen B ym. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens 2005;23:475-81 «PMID: 15716684»PubMed
  160. Williamson JD, Supiano MA, Applegate WB ym. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged =75 Years: A Randomized Clinical Trial. JAMA 2016;315:2673-82 «PMID: 27195814»PubMed
  161. Wiysonge CS, Bradley H, Mayosi BM ym. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007;:CD002003 «PMID: 17253471»PubMed
  162. Wright JM, Lee CH, Chambers GK. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ 1999;161:25-32 «PMID: 10420860»PubMed
  163. Wright JT Jr, Bakris G, Greene T ym. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002;288:2421-31 «PMID: 12435255»PubMed
  164. Xin X, He J, Frontini MG ym. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001;38:1112-7 «PMID: 11711507»PubMed
  165. Yusuf S, Diener HC, Sacco RL ym. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008;359:1225-37 «PMID: 18753639»PubMed
  166. Zhang Y, Zhang X, Liu L ym. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J 2011;32:1500-8 «PMID: 21345850»PubMed